World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
23751
World Ranking
17522
National Ranking
1587

Christopher M. Nutting publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christopher M. Nutting sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 472 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christopher M. Nutting D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher M. Nutting sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Christopher M. Nutting is affiliated with the Royal Marsden NHS Foundation Trust in the United Kingdom. Their primary field of study is Medicine, with a focus on several subfields including Otorhinolaryngology, Surgery, Pulmonary and Respiratory Medicine, Oncology, and Speech and Hearing.

The scientist's research centers predominantly on Head and Neck Cancer Studies, with significant contributions also made in Dysphagia Assessment and Management, Advanced Radiotherapy Techniques, Cancer Diagnosis and Treatment, Head and Neck Surgical Oncology, Oral Health in Cancer Treatment, and the Management of Metastatic Bone Disease.

Frequent co-authors include Kevin J. Harrington, Kate Newbold, Emma Hall, Shreerang Bhide, and Justin Roe, reflecting extensive collaborative research activity.

Key recent papers include:

  • "Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial," 2023, The Lancet Oncology
  • "Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer," 2021, Journal of Clinical Oncology
  • "Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy," 2020, European Journal of Cancer
  • "Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer," 2020, Journal of Clinical Oncology
  • "Transoral robotic surgery for recurrent cancers of the upper aerodigestive tract-Systematic review and meta-analysis," 2020, Head & Neck

They have published extensively in several venues. The most frequent publication venues are Journal of Clinical Oncology, Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, The Lancet Oncology, and European Journal of Cancer.

Christopher M. Nutting has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom, acknowledging contributions to medical research and practice.

Best Publications

  • Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

    Christopher M Nutting;Christopher M Nutting;James P Morden;Kevin J Harrington;Kevin J Harrington;Teresa Guerrero Urbano

  • Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

    Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei

  • Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines

    Vincent Grégoire;Kian Ang;Wilfried Budach;Cai Grau

  • Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

    Ujjal Mallick;Clive Harmer;Beng K. Yap;Jonathan Wadsley

  • A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

    Jennifer C.C. Hu;Robert S. Coffin;Ceri J. Davis;Nicola J. Graham

  • PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer

    Hisham Mehanna;Wai-Lup Wong;Christopher C. McConkey;Joy K. Rahman

  • CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

    Charlotte L. Brouwer;Roel J.H.M. Steenbakkers;Jean Bourhis;Wilfried Budach

  • Stereotactic body radiotherapy for oligometastases.

    Alison C Tree;Vincent S Khoo;Rosalind A Eeles;Merina Ahmed

  • Head and neck cancer—Part 1: Epidemiology, presentation, and prevention

    H Mehanna;V Paleri;C M L West;C Nutting

  • Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer.

    Christopher M Nutting;David J Convery;Vivian P Cosgrove;Carl Rowbottom

  • Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

    D P Dearnaley;E Hall;D Lawrence;R A Huddart

  • Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

    Kevin J. Harrington;Mohan Hingorani;Mary Anne Tanay;Jennifer Hickey

  • Intensity modulated radiation therapy: a clinical review.

    C Nutting;D P Dearnaley;S Webb

  • Weekly Volume and Dosimetric Changes During Chemoradiotherapy With Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Observational Study

    Shreerang A. Bhide;Mark Davies;Kevin Burke;Helen A. McNair

  • Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population.

    Merina Ahmed;Yolanda Barbachano;Angela Riddell;Jen Hickey

  • Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels

    M. Teresa Guerrero Urbano;Anthony J. Henrys;Elisabeth J. Adams;Andrew R. Norman

  • A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy

    Christopher M Nutting;James L Bedford;Vivian P Cosgrove;Diana M Tait

  • HPV-related oropharynx cancer in the United Kingdom: An evolution in the understanding of disease etiology

    Andrew G. Schache;Ned G. Powell;Kate S. Cuschieri;Max Robinson

  • Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies

    Eleni Karapanagiotou;Victoria Roulstone;Katie Twigger;Mercel Ball

  • Radiotherapy in the treatment of benign meningioma of the skull base

    Christopher Nutting;Michael Brada;Lucy Brazil;Ahmen Sibtain

Frequent Co-Authors

Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Alan Melcher
Alan Melcher Institute of Cancer Research
Martin O. Leach
Martin O. Leach Royal Marsden NHS Foundation Trust
Roxy Senior
Roxy Senior National Health Service
Suzanne A. Eccles
Suzanne A. Eccles Institute of Cancer Research
Steven I. Sherman
Steven I. Sherman The University of Texas MD Anderson Cancer Center
Roger A'Hern
Roger A'Hern Royal Marsden NHS Foundation Trust
Robert Huddart
Robert Huddart Institute of Cancer Research
Martin Gore
Martin Gore Royal Marsden NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn't mean you must follow a traditional path. Online healthcare degrees offer flexibility for busy students and professionals. For those interested in healthcare management, you can explore the cahme accredited online mha programs list, which provides trusted options for a Master of Health Administration fully online.

If you are a registered nurse seeking advancement, the rn to bsn no clinical hours programs allow working nurses to earn a Bachelor of Science in Nursing without additional clinicals.

For advanced practice nurses aiming for the highest degree in nursing, there are efficient routes such as the fastest msn to dnp program. These programs are designed for speed while maintaining quality standards.

Additionally, you can review online dnp programs to compare flexibility, curriculum, and admission requirements. Exploring these degree options is a practical next step for those pursuing healthcare careers beyond traditional medical school.

Best Scientists Citing Christopher M. Nutting

Trending Scientists

Recently Published Articles